Aarti Pharmalabs Limited (AARTIPHARM) - Total Assets
Based on the latest financial reports, Aarti Pharmalabs Limited (AARTIPHARM) holds total assets worth Rs29.06 Billion INR (≈ $314.32 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Aarti Pharmalabs Limited (AARTIPHARM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Aarti Pharmalabs Limited - Total Assets Trend (2020–2025)
This chart illustrates how Aarti Pharmalabs Limited's total assets have evolved over time, based on quarterly financial data. See Aarti Pharmalabs Limited (AARTIPHARM) net assets for net asset value and shareholders' equity analysis.
Aarti Pharmalabs Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Aarti Pharmalabs Limited's total assets of Rs29.06 Billion consist of 45.5% current assets and 54.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.3% |
| Accounts Receivable | Rs5.76 Billion | 19.8% |
| Inventory | Rs5.88 Billion | 20.2% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs984.39 Million | 3.4% |
| Goodwill | Rs17.81 Million | 0.1% |
Asset Composition Trend (2020–2025)
This chart illustrates how Aarti Pharmalabs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Aarti Pharmalabs Limited worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aarti Pharmalabs Limited's current assets represent 45.5% of total assets in 2025, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 100.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 20.2% of total assets.
Aarti Pharmalabs Limited Competitors by Total Assets
Key competitors of Aarti Pharmalabs Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.84 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.39 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
Aarti Pharmalabs Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.01 | 1.94 | 17.14 |
| Quick Ratio | 1.12 | 1.01 | 17.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs6.65 Billion | Rs6.51 Billion | Rs2.11 Million |
Aarti Pharmalabs Limited - Advanced Valuation Insights
This section examines the relationship between Aarti Pharmalabs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.01 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 12.6% |
| Total Assets | Rs29.06 Billion |
| Market Capitalization | $654.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aarti Pharmalabs Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Aarti Pharmalabs Limited's assets grew by 12.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Aarti Pharmalabs Limited (2020–2025)
The table below shows the annual total assets of Aarti Pharmalabs Limited from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs29.06 Billion ≈ $314.32 Million |
+12.56% |
| 2024-03-31 | Rs25.82 Billion ≈ $279.24 Million |
+15.07% |
| 2023-03-31 | Rs22.44 Billion ≈ $242.68 Million |
+10.01% |
| 2022-03-31 | Rs20.40 Billion ≈ $220.61 Million |
+815859.84% |
| 2021-03-31 | Rs2.50 Million ≈ $27.04K |
0.00% |
| 2020-03-31 | Rs2.50 Million ≈ $27.04K |
-- |
About Aarti Pharmalabs Limited
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous sys… Read more